Opthea Price Prediction
| OPTDelisted Stock | USD 3.41 0.07 2.01% |
Momentum 33
Sell Stretched
Oversold | Overbought |
Using Opthea hype-based prediction, you can estimate the value of Opthea from the perspective of Opthea response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Opthea to buy its stock at a price that has no basis in reality. In that case, they are not buying Opthea because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Opthea after-hype prediction price | USD 3.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Opthea |
Opthea After-Hype Price Prediction Density Analysis
As far as predicting the price of Opthea at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Opthea or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Opthea, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Opthea Estimiated After-Hype Price Volatility
In the context of predicting Opthea's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Opthea's historical news coverage. Opthea's after-hype downside and upside margins for the prediction period are 3.41 and 3.41, respectively. We have considered Opthea's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Opthea is very steady at this time. Analysis and calculation of next after-hype price of Opthea is based on 3 months time horizon.
Opthea Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Opthea is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opthea backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Opthea, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.41 | 3.41 | 0.00 |
|
Opthea Hype Timeline
On the 26th of December Opthea is traded for 3.41. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Opthea is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Opthea is about 0.0%, with the expected price after the next announcement by competition of 3.41. The company recorded a loss per share of 2.25. Opthea had not issued any dividends in recent years. The entity had 5:8 split on the 15th of October 2020. Considering the 90-day investment horizon the next projected press release will be uncertain. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.Opthea Related Hype Analysis
Having access to credible news sources related to Opthea's direct competition is more important than ever and may enhance your ability to predict Opthea's future price movements. Getting to know how Opthea's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Opthea may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRTX | Mirati Ther | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ALPN | Alpine Immune Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RYZB | RayzeBio, Common Stock | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CBAY | Cymabay Therapeu | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SWTX | SpringWorks Therapeutics | (0.03) | 11 per month | 2.82 | (0) | 5.93 | (6.92) | 20.32 | |
| ISEE | IVERIC Bio | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SYNH | Syneos Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MOR | MorphoSys AG ADR | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MORF | Morphic Holding | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ABCM | Abcam PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Opthea Additional Predictive Modules
Most predictive techniques to examine Opthea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Opthea using various technical indicators. When you analyze Opthea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Opthea Predictive Indicators
The successful prediction of Opthea stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Opthea, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Opthea based on analysis of Opthea hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Opthea's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Opthea's related companies.
Story Coverage note for Opthea
The number of cover stories for Opthea depends on current market conditions and Opthea's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Opthea is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Opthea's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Opthea Short Properties
Opthea's future price predictability will typically decrease when Opthea's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Opthea often depends not only on the future outlook of the potential Opthea's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Opthea's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.8 M | |
| Cash And Short Term Investments | 172.5 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Opthea Stock
If you are still planning to invest in Opthea check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Opthea's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |